Phase I study of lapatinib plus vinorelbine in patients with locally advanced or metastatic breast cancer overexpressing HER2.
about
Preclinical Data on Efficacy of 10 Drug-Radiation Combinations: Evaluations, Concerns, and RecommendationsMetabolism-related pharmacokinetic drug-drug interactions with tyrosine kinase inhibitors: current understanding, challenges and recommendations.Phase II study on the efficacy and safety of Lapatinib administered beyond disease progression and combined with vinorelbine in HER-2/neu- positive advanced breast cancer: results of the CECOG LaVie trial.Efficacy and mechanism of action of the tyrosine kinase inhibitors gefitinib, lapatinib and neratinib in the treatment of HER2-positive breast cancer: preclinical and clinical evidenceA phase II, randomized, multicenter study evaluating the combination of lapatinib and vinorelbine in women with ErbB2 overexpressing metastatic breast cancer.Pharmacokinetic drug-drug interactions of tyrosine kinase inhibitors: A focus on cytochrome P450, transporters, and acid suppression therapy.Phase II, open-label trial of lapatinib and vinorelbine in women with previously treated HER2-positive metastatic breast cancer.
P2860
Q26767798-B83C2BD7-371E-469D-88AB-5A8330FD40A1Q35023711-7C758283-59CF-4797-9798-00241F5F5967Q35926639-5E680753-279F-4E67-8217-3C5AD99C329AQ36250585-E7C11C04-B8BB-4303-BA43-877C77ACE771Q37534928-AE5D6EFC-F3DB-426D-86AC-2E1A8753FB1EQ39031326-B54A30BC-86A2-49EE-AE72-AE4FB22EB537Q44179284-1F5FB20B-79B3-4838-8608-85D206B23BBC
P2860
Phase I study of lapatinib plus vinorelbine in patients with locally advanced or metastatic breast cancer overexpressing HER2.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Phase I study of lapatinib plu ...... st cancer overexpressing HER2.
@ast
Phase I study of lapatinib plu ...... st cancer overexpressing HER2.
@en
type
label
Phase I study of lapatinib plu ...... st cancer overexpressing HER2.
@ast
Phase I study of lapatinib plu ...... st cancer overexpressing HER2.
@en
prefLabel
Phase I study of lapatinib plu ...... st cancer overexpressing HER2.
@ast
Phase I study of lapatinib plu ...... st cancer overexpressing HER2.
@en
P2093
P2860
P356
P1476
Phase I study of lapatinib plu ...... st cancer overexpressing HER2.
@en
P2093
C Mahier-Aït Oukhatar
F Mefti-Lacheraf
J Bonneterre
L Vanlemmens
P2860
P2888
P304
P356
10.1038/BJC.2011.591
P407
P577
2012-01-12T00:00:00Z